UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company advancing the commercialisation of AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce that it has completed the manufacture of its next-generation Edge AI Intoxication Detection Kiosk. Read More